Lysostaphin and clarithromycin: a promising combination for the eradication of Staphylococcus aureus biofilms.

Jun 1, 2011 | Magazine: International Journal of Antimicrobial Agents

Aguinaga A, Francés ML, Del Pozo JL, Alonso M, Serrera A, Lasa I, Leiva J.

The difficulty of treating biofilm-associated infections has inspired the study of new treatment targets as well as combinations of new substances and antimicrobials with different mechanisms of action.

Lysostaphin is an endopeptidase extracted from Staphylococcus simulans biovar staphylolyticus that cleaves the pentaglycine cross-links in the cell walls of Staphylococcus spp., lysing bacteria.

CITATION Int J Antimicrob Agents. 2011 Jun;37(6):585-7

see publication in pubmed